Core Viewpoint - The collaboration between Shengxiang Bio and Alibaba Health represents a deep synergy of the company's "three-in-one" model and the "medical-testing-pharmacy integration" ecosystem, aiming to enhance home-based medical services and promote standardized health testing solutions [1] Group 1: Collaboration and Services - The partnership focuses on the "Respiratory Virus and Bacteria 12-in-1 Testing" project, allowing users to complete professional-level testing from home, with reports generated in an average of 3 hours, thereby alleviating the pressure on healthcare systems during flu seasons [1] - Future initiatives will include the standardization and nationwide promotion of home rapid testing services, as well as the exploration of additional home-based applications for infectious disease testing [1] Group 2: Health Ecosystem Development - The collaboration aims to drive the precision and accessibility of serious medical services, transitioning health demands towards proactive and consumer-oriented approaches [1] - The goal is to lead health consumption towards a more serious, scientific, and personalized direction, ensuring tailored health management solutions benefit every individual [1]

Core Viewpoint - The collaboration between Shengxiang Bio and Alibaba Health aims to provide a home-based rapid testing service for respiratory diseases, addressing the rising flu activity in China and alleviating the pressure on healthcare facilities during the flu season [1][2]. Group 1: Company Collaboration - Shengxiang Bio has become the exclusive supplier for Alibaba Health's home-based rapid testing service, launching the "12-pathogen respiratory virus and bacteria test" project [1]. - The service allows users to receive professional-level testing results within an average of 3 hours without leaving their homes, thus providing a scientific basis for medication and reducing the burden on healthcare systems [1][2]. Group 2: Service Implementation - The home-based rapid testing service is initially available in four cities: Beijing, Shanghai, Guangzhou, and Hangzhou, with 17 service points established [2]. - Users can book the service through the Taobao app, where trained couriers will deliver sampling kits and assist in sample collection, which is then sent to certified laboratories for testing [2]. Group 3: Industry Trends - The home testing industry is experiencing rapid growth, with projections indicating that the market size for home self-testing in China will increase from 120 billion yuan to 280 billion yuan between 2025 and 2030, reflecting a compound annual growth rate of 18.5% [3]. - The partnership is seen as a significant step towards standardizing home rapid testing services and expanding the range of infectious disease testing applications in the future [3].